Skip to content

A clinical trial to evaluate the efficacy and safety of urethral stent systems in the treatment of dysuria due to Benign prostatic hyperplasia

A clinical trial to evaluate the efficacy and safety of urethral stent systems in the treatment of dysuria due to Benign prostatic hyperplasia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071172
Enrollment
Unknown
Registered
2023-05-06
Start date
2023-05-08
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

Experimental group:Urethral stent implantation

Sponsors

SUN YAT-SEN MEMORIAL HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age>18, = 80 years old; 2) Understand the content of this clinical trial and voluntarily participate, willing to cooperate with the trial process and sign an informed consent form; 3) Prostate hyperplasia leading to difficulty urinating requires surgery or medication intervention;

Exclusion criteria

Exclusion criteria: 1) Urethral stricture caused by diseases other than prostatic hyperplasia; 2) Patients with obstructive symptoms mainly caused by mid-lobe hyperplasia; 3) Patients whose prostate size or shape is judged by the investigator to be unsuitable for stent placement; 4) Patients with malignant tumors;

Design outcomes

Primary

MeasureTime frame
The Maximum urine flow rate;

Secondary

MeasureTime frame
International Prostate Symptom Score;QUALITY OF LIFE SCORE;Numerical Rating Scale;the Overactive Bladder Symptom Score;International Index of Erectile Function 5;the Bladder Post-void Residual Volume;

Countries

China

Contacts

Public ContactJian Huang

SUN YAT-SEN MEMORIAL HOSPITAL

hjgcp2017@163.com+86 13600054033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026